Article
Validating S100A16 as a prognostic and immunological biomarker in pan-cancer and lung adenocarcinoma through integrated Single-cell Sequencing Analysis
2024-02-28
Abstract excerpt
<h4>Background: </h4> S100A16 belongs to the S100 protein family, exhibiting different expression levels across several human tumors. S100A16 upregulation in many malignancies suggests its potential role in malignant transformation. However, the specific involvement of S100A16 in lung adenocarcinoma (LUAD) remains unclear. Methods This study utilized RNA sequencing and protein expression data from the Cancer Geno...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- daf6b29a-7b5d-5ebb-a1d3-89a63a9c8e26
- DOI
- 10.21203/rs.3.rs-3914587/v1
